Roundhill Glp-1 & Weight ... (OZEM)

NasdaqGM: OZEM · Echtzeitkurs · USD

34.00

+1.06 (3.22%)

Zum Schluss: Aug 19, 2026, 2:29 PM

3.22% (1D)

Keine Daten verfügbar

Geld	23.33
Marktkapitalisierung	n/a
Umsatz (TTM)	n/a
Nettogewinn (TTM)	n/a
Beta	n/a
EPS (ttm)	n/a
KGV (TTM)	15
Forward-KGV	n/a
KBV (TTM)	n/a
KUV (TTM)	n/a
Earnings Date	n/a

Brief	41.71
Volumen	30,049
Ø Vol. (20D)	23,798
Eröffnung	32.96
Vortagesschluss	32.94
Tagesspanne	32.96 - 33.25
52-Wk Range	25.05 - 37.15
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über OZEM

The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified....

[Mehr lesen]

Branche n/a

Sektor n/a

IPO Datum May 21, 2024

Mitarbeiter n/a

Börse NasdaqGM

Tickersymbol OZEM

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr undefined betrug der Umsatz von Roundhill Glp-1 & Weight Loss ETF n/a, ein Anstieg von undefined% im Vergleich zum Vorjahr (n/a). Der Gewinn lag bei n/a, ein Anstieg von undefined %.

Finanzberichte

Nachrichten

vor 1 Monat · Zacks

Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage

Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified way to tap growth across the obesity treatment market.

vor 2 Monaten · MarketBeat

3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend

With GLP-1 usage continuing to rise, a group of unlikely beneficiaries is emerging; stocks in the broader health care sector and even in retail could stand out.